4.3 Article

Use of the Mirena™ LNG-IUS and Paragard™ CuT380A intrauterine devices in nulliparous women

Journal

CONTRACEPTION
Volume 81, Issue 5, Pages 367-371

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.contraception.2010.01.010

Keywords

Intrauterine device; Intrauterine contraception; Intrauterine system; IUD; IUS; Nulliparity

Ask authors/readers for more resources

Two intrauterine devices (IUDs) are available in the United States, the levonorgestrel-bearing intrauterine system (Mirena (TM)) and the copper-bearing T380A (Paragard (TM)). These devices have very low typical-use failure rates but are used by only a minority of women. In particular, there is concern about their use in nulliparous women. We review the available data to address common concerns about using IUDs in this population and show that nulliparous women desiring effective contraception should be considered candidates for IUDs. (C) 2010 Elsevier Inc. All rights reserved.

Authors

Anonymous

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Obstetrics & Gynecology

Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses

Mia Schmidt-Hansen, Sharon Cameron, Patricia A. Lohr, Elise Hasler

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)

Article Obstetrics & Gynecology

Modern methods to induce abortion: Safety, efficacy and choice

Nathalie Kapp, Patricia A. Lohr

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)

Review Family Studies

Surgical or medical abortion of pregnancies between 13+0 and 23+6 weeks' gestation? A systematic review and new NICE national guidelines

Mia Schmidt-Hansen, Patricia A. Lohr, Sharon Cameron, Elise Hasler

Summary: When considering abortion between 13 and 23 weeks gestation, the choice between surgical and medical methods may impact the completion of abortion, with medical methods showing a higher rate of incomplete abortion requiring surgical intervention. However, other complications such as hemorrhage, uterine injury, and infection did not significantly differ between the two methods. Patient satisfaction may vary, depending on measurement methods.

BMJ SEXUAL & REPRODUCTIVE HEALTH (2021)

Editorial Material Family Studies

The impact of COVID-19 on contraception and abortion care policy and practice: experiences from selected countries

Deborah J. Bateson, Patricia A. Lohr, Wendy V. Norman, Caroline Moreau, Kristina Gemzell-Danielsson, Paul D. Blumenthal, Lesley Hoggart, Hang-Wun Raymond Li, Abigail R. A. Aiken, Kirsten I. Black

BMJ SEXUAL & REPRODUCTIVE HEALTH (2020)

Review Obstetrics & Gynecology

Expulsion at home for early medical abortion: A systematic review with meta-analyses

Mia Schmidt-Hansen, Anuja Pandey, Patricia A. Lohr, Michael Nevill, Peter Taylor, Elise Hasler, Sharon Cameron

Summary: A systematic review found that the upper gestational limit for home expulsion in medical abortion is 10 weeks, and further research is needed to determine whether this limit can be extended beyond 10 weeks.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2021)

Article Education & Educational Research

What should medical students be taught about abortion? An evaluation of student attitudes towards their abortion teaching and their future involvement in abortion care

Pollyanna Cohen, Jonathan Mayhew, Faye Gishen, Henry W. W. Potts, Patricia A. Lohr, Jayne Kavanagh

Summary: The study surveyed students at University College London Medical School on their opinions of abortion teaching and their attitudes towards abortion. The majority of students supported the right to choose abortion and found the teaching important and diverse, but some students with anti-abortion beliefs expressed lower willingness to be involved in future abortion care.

BMC MEDICAL EDUCATION (2021)

Article Obstetrics & Gynecology

Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study

A. R. A. Aiken, P. A. Lohr, J. Lord, N. Ghosh, J. Starling

Summary: A comparison study of over 52,000 women shows that medical abortion without ultrasound via telemedicine is safe, effective, and improves access to care.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Editorial Material Obstetrics & Gynecology

Telemedicine trailblazers pave the way to better abortion care for all

Patricia A. Lohr

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Family Studies

Client perspectives on choice of abortion method in England and Wales

Rebecca Blaylock, Shelly Makleff, Katherine C. Whitehouse, Patricia A. Lohr

Summary: Our study analyzed qualitative data to examine patient perspectives on abortion method choice and barriers to meeting them. Participants' preferences for abortion method were shaped by factors such as prior experience, accessibility, perceptions of risk, and information gathering. Providers should aim to restore and expand treatment options for abortion when possible, especially in response to constraints imposed by the COVID-19 pandemic.

BMJ SEXUAL & REPRODUCTIVE HEALTH (2022)

Editorial Material Family Studies

Moderate (conscious) sedation in abortion care

Ceres Hammenga, David Craig, Patricia A. Lohr

BMJ SEXUAL & REPRODUCTIVE HEALTH (2022)

Article Obstetrics & Gynecology

Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation

Katherine C. Whitehouse, Tara Shochet, Patricia A. Lohr

Summary: This study assessed the effectiveness of a low-sensitivity pregnancy test in identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation. The results showed that the low-sensitivity pregnancy test had high sensitivity and negative predictive value for detecting ongoing pregnancy.

CONTRACEPTION (2022)

Article Family Studies

Should COVID-specific arrangements for abortion continue? The views of women experiencing abortion in Britain during the pandemic

Patricia A. Lohr, Maria Lewandowska, Rebecca Meiksin, Natasha Salaria, Sharon Cameron, Rachel H. Scott, Jennifer Reiter, Melissa J. Palmer, Rebecca S. French, Kaye Wellings

Summary: This study interviewed 30 women who had undergone abortion in England, Scotland, or Wales and found that there was overwhelming support for using medical abortion pills at home and continuing the telemedical model. The reasons cited for this support included convenience, comfort, reduced stigma, privacy, and respect for autonomy.

BMJ SEXUAL & REPRODUCTIVE HEALTH (2022)

Article Family Studies

Abortion education in UK medical schools: a survey of medical educators

Catriona Rennison, Emily Jane Woodhead, Corrina Horan, Patricia A. Lohr, Jayne Kavanagh

Summary: This study investigated the current provision of undergraduate abortion education in UK medical schools. The findings showed significant variations in the attention given to abortion education among medical schools, with most educators facing barriers and expressing a need for further guidance.

BMJ SEXUAL & REPRODUCTIVE HEALTH (2022)

Article Obstetrics & Gynecology

Impact of approval of home use of misoprostol in England on access to medical abortion: An interrupted time series analysis

Maria Lewandowska, Daniel J. Carter, Antonio Gasparrini, Patricia A. Lohr, Kaye Wellings

Summary: The approval of home use of misoprostol in England for early medical abortions had a positive impact on abortion access. The proportion of medical abortions increased and the gestational age decreased after the approval. This improvement was more significant in deprived areas but not equal across all racial/ethnic groups.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Review Obstetrics & Gynecology

Cervical priming before surgical abortion between 14 and 24 weeks: a systematic review and meta-analyses for the National Institute for Health and Care Excellence-new clinical guidelines for England

Laura E. O'Shea, Patricia A. Lohr, Jonathan Lord, Elise Hasler, Sharon Cameron

Summary: This study analyzed 15 randomized controlled trials and found that using osmotic dilators, misoprostol, or mifepristone before abortion can improve the smoothness of the procedure at 14 to 16 weeks of gestation; for pregnancies at 16(+1) to 19(+0) weeks' gestation, osmotic dilators or misoprostol are more effective; and for pregnancies at 19(+1) to 24(+0) weeks' gestation, using osmotic dilators alone or in combination with mifepristone is more effective. Future research should focus on the effectiveness of pharmacologic agents alone beyond 16(+0) weeks' gestation and the optimal timing of dilator placement.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

No Data Available